TNL Mediagene [TNMG] vs John Wiley & Sons [WLY] Detailed Stock Comparison
TNL Mediagene
NASDAQ
Loading...
John Wiley & Sons
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: TNL Mediagene wins in 6 metrics, John Wiley & Sons wins in 7 metrics, with 0 ties. John Wiley & Sons appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TNL Mediagene | John Wiley & Sons | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 25.31 | N/A |
| Price-to-Book Ratio | 0.31 | 2.75 | TNL Mediagene |
| Debt-to-Equity Ratio | 0.64 | 120.01 | TNL Mediagene |
| PEG Ratio | N/A | 10.47 | N/A |
| EV/EBITDA | -0.73 | 9.43 | TNL Mediagene |
| Profit Margin (TTM) | 36.58% | 5.02% | TNL Mediagene |
| Operating Margin (TTM) | -159.10% | 18.18% | John Wiley & Sons |
| EBITDA Margin (TTM) | N/A | 18.18% | N/A |
| Return on Equity | -233.51% | 11.28% | John Wiley & Sons |
| Return on Assets (TTM) | -91.49% | 5.50% | John Wiley & Sons |
| Free Cash Flow (TTM) | $-10.58M | $119.82M | John Wiley & Sons |
| Dividend Yield | N/A | 3.29% | N/A |
| 1-Year Return | -96.33% | -14.41% | John Wiley & Sons |
| Price-to-Sales Ratio (TTM) | 0.26 | 1.24 | TNL Mediagene |
| Enterprise Value | $32.30M | $2.86B | John Wiley & Sons |
| EV/Revenue Ratio | 0.67 | 1.71 | TNL Mediagene |
| Gross Profit Margin (TTM) | N/A | 74.93% | N/A |
| Revenue per Share (TTM) | N/A | $31 | N/A |
| Earnings per Share (Diluted) | $-3.46 | $1.53 | John Wiley & Sons |
| Beta (Stock Volatility) | N/A | 0.96 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
TNL Mediagene vs John Wiley & Sons Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TNL Mediagene | 0.47% | 4.88% | -6.52% | 38.71% | -82.08% | -94.18% |
| John Wiley & Sons | 1.12% | 1.36% | -9.21% | -13.66% | -4.06% | -10.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TNL Mediagene | -96.33% | -96.33% | -96.33% | -96.33% | -96.33% | -96.33% |
| John Wiley & Sons | -14.41% | -27.58% | 12.00% | -26.35% | 4.87% | -9.78% |
Performance & Financial Health Analysis: TNL Mediagene vs John Wiley & Sons
| Metric | TNMG | WLY |
|---|---|---|
| Market Information | ||
| Market Cap | $12.81M | $2.08B |
| Market Cap Category | Micro cap | Mid cap |
| 10 Day Avg. Volume | 314,398 | 459,715 |
| 90 Day Avg. Volume | 190,499 | 559,713 |
| Last Close | $0.43 | $38.73 |
| 52 Week Range | $0.26 - $34.08 | $36.50 - $53.96 |
| % from 52W High | -98.75% | -28.22% |
| All-Time High | $34.08 (Dec 02, 2024) | $71.75 (Jun 11, 2018) |
| % from All-Time High | -98.74% | -46.02% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | -0.06% |
| Quarterly Earnings Growth | N/A | 1.70% |
| Financial Health | ||
| Profit Margin (TTM) | 0.37% | 0.05% |
| Operating Margin (TTM) | -1.59% | 0.18% |
| Return on Equity (TTM) | -2.34% | 0.11% |
| Debt to Equity (MRQ) | 0.64 | 120.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.39 | $14.09 |
| Cash per Share (MRQ) | N/A | $1.61 |
| Operating Cash Flow (TTM) | $-36,835,261 | $202.59M |
| Levered Free Cash Flow (TTM) | $-85,004,692 | $165.48M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 3.29% |
| Last 12-Month Dividend | N/A | $1.40 |
Valuation & Enterprise Metrics Analysis: TNL Mediagene vs John Wiley & Sons
| Metric | TNMG | WLY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 25.31 |
| Forward P/E | N/A | 10.47 |
| PEG Ratio | N/A | 10.47 |
| Price to Sales (TTM) | 0.26 | 1.24 |
| Price to Book (MRQ) | 0.31 | 2.75 |
| Market Capitalization | ||
| Market Capitalization | $12.81M | $2.08B |
| Enterprise Value | $32.30M | $2.86B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | 1.71 |
| Enterprise to EBITDA | -0.73 | 9.43 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.96 |
| Book Value per Share (MRQ) | $1.39 | $14.09 |
Financial Statements Comparison: TNL Mediagene vs John Wiley & Sons
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TNMG | WLY |
|---|---|---|
| Revenue/Sales | N/A | $442.58M |
| Cost of Goods Sold | N/A | $110.94M |
| Gross Profit | N/A | $331.64M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $88.96M |
| EBITDA | N/A | $128.19M |
| Pre-Tax Income | N/A | $52.27M |
| Income Tax | N/A | $-15.83M |
| Net Income (Profit) | N/A | $68.09M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TNMG | WLY |
|---|---|---|
| Cash & Equivalents | $3.65M | $85.88M |
| Total Current Assets | $17.72M | $439.88M |
| Total Current Liabilities | $32.99M | $820.86M |
| Long-Term Debt | $10.39M | $870.92M |
| Total Shareholders Equity | $36.40M | $752.21M |
| Retained Earnings | $-117.21M | $1.59B |
| Property, Plant & Equipment | $100,203 | $66.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TNMG | WLY |
|---|---|---|
| Operating Cash Flow | N/A | $110.07M |
| Capital Expenditures | N/A | $-19.13M |
| Free Cash Flow | N/A | $125.11M |
| Debt Repayment | N/A | $-253.68M |
| Common Stock Repurchase | N/A | $-25.00M |
Short Interest & Institutional Ownership Analysis
| Metric | TNMG | WLY |
|---|---|---|
| Shares Short | 54,828 | 2.01M |
| Short Ratio | 0.02 | 2.56 |
| Short % of Float | N/A | 0.06% |
| Average Daily Volume (10 Day) | 314,398 | 459,715 |
| Average Daily Volume (90 Day) | 190,499 | 559,713 |
| Shares Outstanding | 26.10M | 53.39M |
| Float Shares | N/A | 40.38M |
| % Held by Insiders | 0.00% | 0.10% |
| % Held by Institutions | 0.01% | 1.00% |
Dividend Analysis & Yield Comparison: TNL Mediagene vs John Wiley & Sons
| Metric | TNMG | WLY |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.40 |
| Last 12-Month Dividend Yield | N/A | 3.29% |
| 3-Year Avg Annual Dividend | N/A | $1.52 |
| 3-Year Avg Dividend Yield | N/A | 0.93% |
| 3-Year Total Dividends | N/A | $4.55 |
| Ex-Dividend Date | N/A | Apr 08, 2025 |